Zobrazeno 1 - 10
of 260
pro vyhledávání: '"Harold J. Wanebo"'
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
PDF file - 67K, Odds Ratio and Hazard Ratio (with 95% Confidence Interval) with A Unit Increase in the Form of log10 Transformation in AQUA Scores by Biomarker.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aee9bef0ccbacaf8393056cb7f7104
https://doi.org/10.1158/1078-0432.22455212.v1
https://doi.org/10.1158/1078-0432.22455212.v1
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
PDF file - 61K, Kaplan-Meier estimates of (a) overall survival, (b) progression-free survival by PIK3CA, NRAS, and PTEN cluster status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073cd1a29d5674c8e5f797b17004f3db
https://doi.org/10.1158/1078-0432.22455227
https://doi.org/10.1158/1078-0432.22455227
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
PDF file - 53K, Kaplan-Meier estimates of (a) overall survival, (b) progression-free survival by PIK3CA, PTEN, and Akt cluster status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ef2ea16ffd103e61e2c3744e174a14
https://doi.org/10.1158/1078-0432.22455224
https://doi.org/10.1158/1078-0432.22455224
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
PDF file - 64K, Summary of Biomarker AQUA Scores at Baseline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac014f69dee662097c0ad18ce78d9c5f
https://doi.org/10.1158/1078-0432.22455215
https://doi.org/10.1158/1078-0432.22455215
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
PDF file - 65K, REMARK Flow Chart of E2303 translational research study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1767077c3e1414eca1f251214c6d5baa
https://doi.org/10.1158/1078-0432.22455230
https://doi.org/10.1158/1078-0432.22455230
Autor:
Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
Purpose: We sought to evaluate the correlation between tissue biomarker expression (using standardized, quantitative immunofluorescence) and clinical outcome in the E2303 trial.Experimental Design: Sixty-three eligible patients with operable stage II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9bf395481842eac9d6b7d44043d18dc
https://doi.org/10.1158/1078-0432.c.6522959
https://doi.org/10.1158/1078-0432.c.6522959
Publikováno v:
Journal of Surgical Oncology. 112:658-661
Radiation associated sarcoma is a significant consequence of cancer therapy. Incidence of radiation associated sarcoma correlates with overall radiotherapy exposure. Prognosis is generally poor with 5 year survival rates lower than that for spontaneo
Autor:
Barbara Burtness, Ju Whei Lee, Eirini Pectasides, Efstratios K. Kosmidis, David L. Rimm, Arlene A. Forastiere, Amanda Psyrri, Harold J. Wanebo, Maria Vassilakopoulou
Publikováno v:
Clinical Cancer Research. 20:3023-3032
Purpose: We sought to evaluate the correlation between tissue biomarker expression (using standardized, quantitative immunofluorescence) and clinical outcome in the E2303 trial. Experimental Design: Sixty-three eligible patients with operable stage I
Autor:
Harold J. Wanebo
Publikováno v:
Cancer Research. 79:4294-4294
The 5% survival of pancreatic cancer emphasizes need for new treatment strategies. Our studies suggest potential value of C6Ceramide (C6Cer) as a chemotherapeutic adjunct. The current study demonstrates that combination chemotherapy of Paclitaxel wit
Autor:
Harold J. Wanebo, Thomas Carbone, Fang Ji, Gabriella Brum, Garret Cammarata, Charles Best, David Calianese, Wen Di, Kevin Szulak, Eric Still, Katelyn Higgins, Yinsheng Wan
Publikováno v:
Oncology Letters
Exogenous cell-permeable C6 ceramide has been demonstrated to act synergistically with chemotherapeutic drugs, including paclitaxel, cisplatin, doxorubicin and the histone deacetylase inhibitor, trichostatin A, to induce cell death in a variety of ca